[Changes in peripheral lymphocyte subsets before and after OK-432 administration in liver cancer].
D000368:Aged; D001688:Biological Products / Q000008:administration & dosage*; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D008214:Lymphocytes / Q000145:classification*; D010844:Picibanil / Q000008:administration & dosage*
D001688:Biological Products; D010844:Picibanil